Literature DB >> 24747239

The FDA's role in the development of medical mobile applications.

J Shuren1.   

Abstract

The use of mobile apps is revolutionizing health-care delivery and has the potential to transform health care by allowing doctors to diagnose patients with potentially life-threatening conditions outside traditional health-care settings, as well as helping consumers manage their own health and wellness and gain access to useful information when and where they need it.

Entities:  

Mesh:

Year:  2014        PMID: 24747239     DOI: 10.1038/clpt.2014.45

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  Big Data Transforms Discovery-Utilization Therapeutics Continuum.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2016-03       Impact factor: 6.875

2.  'Can you recommend any good STI apps?' A review of content, accuracy and comprehensiveness of current mobile medical applications for STIs and related genital infections.

Authors:  Jo Gibbs; Voula Gkatzidou; Laura Tickle; Sarah R Manning; Tilna Tilakkumar; Kate Hone; Richard E Ashcroft; Pam Sonnenberg; S Tariq Sadiq; Claudia S Estcourt
Journal:  Sex Transm Infect       Date:  2016-11-24       Impact factor: 3.519

3.  Commentary: A Breathing-Based Meditation Intervention for Patients with Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study.

Authors:  Skye McKennon; Sarah Elizabeth Levitt; Grzegorz Bulaj
Journal:  Front Med (Lausanne)       Date:  2017-04-06

Review 4.  Combining non-pharmacological treatments with pharmacotherapies for neurological disorders: a unique interface of the brain, drug-device, and intellectual property.

Authors:  Grzegorz Bulaj
Journal:  Front Neurol       Date:  2014-07-14       Impact factor: 4.003

Review 5.  Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases.

Authors:  Grzegorz Bulaj; Margaret M Ahern; Alexis Kuhn; Zachary S Judkins; Randy C Bowen; Yizhe Chen
Journal:  Curr Clin Pharmacol       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.